Diabetes drug Jardiance gains landmark cardiovascular approvalLilly and Boehringer Ingelheim will now be able to promote their drug Jardiance in the US as a Share XDiabetes drug Jardiance gains landmark cardiovascular approvalhttps://pharmaphorum.com/news/jardiancecvapproval/
New drugs boost Lilly in Q1 as company hopes for turnaround yearNew drugs from Eli Lilly have produced a strong showing in the first quarter, in what could be Share XNew drugs boost Lilly in Q1 as company hopes for turnaround yearhttps://pharmaphorum.com/transversal-categories/sales-and-marketing/new-drugs-boost-lilly-as-company-hopes-for-turnaround-year/
